POSTER: CLL-617 Long Term Outcomes and Secondary Malignancies in 673 Patients Treated With Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL) in British Columbia (BC), CanadaElys

VanderVeer, E., Huang, S. J. T., Bruyere, H., Li, C., Ramadan, K., Villa, D., Scott, D. W., Savage, K. J., Connors, J. M., Sehn, L. H., Toze, C. L., & Gerrie, A. S. (2023). POSTER: CLL-617 Long Term Outcomes and Secondary Malignancies in 673 Patients Treated With Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL) in British Columbia (BC), CanadaElys. Clinical Lymphoma Myeloma and Leukemia, 23, S173. https://doi.org/10.1016/s2152-2650(23)00531-1
Authors:
Elysha VanderVeer
Steven J.T. Huang
Hélène Bruyère
Charles Li
Khaled M. A. Ramadan
Diego Villa
David W. Scott
Kerry J. Savage
Joseph M. Connors
Laurie H. Sehn
Cynthia L. Toze
Alina S. Gerrie
Affiliated Authors:
Elysha VanderVeer
Diego Villa
Columbia Affiliation:
Subjects:
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
Efficacy and Resistance in CML Treatment (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1016/s2152-2650(23)00531-1
DOI:
10.1016/s2152-2650(23)00531-1
Journal:
Clinical Lymphoma, Myeloma and Leukemia
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: